Longxiang Pharmaceutical

Longxiang Pharmaceutical is a China-based veterinary pharmaceutical company focused on the research, development, manufacture, and sale of veterinary active pharmaceutical ingredients and specialty formulations. The company emphasizes animal health products for livestock and poultry and markets products including florfenicol, tilmicosin, valnemulin hydrochloride, toltrazuril, flunixin meglumine, and cephalosporin-related veterinary products. It also reports multiple registered new veterinary drugs and a portfolio of patents and provincial/national science projects. Longxiang operates manufacturing facilities in Hubei and appears to have commercialized products and export capabilities, positioning it as an established animal-health manufacturing business rather than a human-therapeutics biotech developer.